CN103316278A - Traditional Chinese medicine for treating herpes zoster - Google Patents
Traditional Chinese medicine for treating herpes zoster Download PDFInfo
- Publication number
- CN103316278A CN103316278A CN2013102530493A CN201310253049A CN103316278A CN 103316278 A CN103316278 A CN 103316278A CN 2013102530493 A CN2013102530493 A CN 2013102530493A CN 201310253049 A CN201310253049 A CN 201310253049A CN 103316278 A CN103316278 A CN 103316278A
- Authority
- CN
- China
- Prior art keywords
- parts
- herpes zoster
- grams
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 239000010231 banlangen Substances 0.000 claims abstract description 9
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 5
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 241000238370 Sepia Species 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 241001529739 Prunella <angiosperm> Species 0.000 claims 1
- 241000879260 Chrysosplenium grayanum Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 241001571466 Potentilla discolor Species 0.000 abstract 1
- 244000299788 selfheal Species 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- AHWQTWBZNABQTO-UHFFFAOYSA-N 3,5-dihydroxy-2-(hydroxymethyl)-6-(1h-indol-3-yloxy)oxan-4-one Chemical compound OC1C(=O)C(O)C(CO)OC1OC1=CNC2=CC=CC=C12 AHWQTWBZNABQTO-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000075634 Cyperus rotundus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032982 Hemorrhagic Fever with Renal Syndrome Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000798443 Hornodermoporus martius Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- KGXOHVOUKNLUNP-ZJQBRPOHSA-N Isatan B Natural products O=C(Oc1c2c([nH]c1)cccc2)[C@@H]1[C@H](O)[C@H](O)[C@@](O)(CO)O1 KGXOHVOUKNLUNP-ZJQBRPOHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 241001441745 Sepia esculenta Species 0.000 description 1
- 241001663378 Sepiella maindroni Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940085771 feverall Drugs 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating herpes zoster, which is prepared from the following medicinal materials in parts by weight: 8 parts of cuttlebone, 12 parts of rhizoma cyperi, 14 parts of fructus amomi, 8 parts of cortex lycii radicis, 12 parts of potentilla discolor, 14 parts of fructus forsythiae, 12 parts of radix isatidis, 4 parts of resina draconis, 13 parts of selfheal, 8 parts of Chrysosplenium grayanum Maxim and 12 parts of rhizoma anemarrhenae. A clinical trial proves that the traditional Chinese medicine can effectively treat herpes zoster.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of herpes zoster.
Background technology
Herpes zoster (herpes zoster) is caused by varicella zoster virus, with bunch collection property phlysis that distributes along one-sided peripheral nerve as feature, often with obvious neuralgia.The sickness rate of primary disease summer and autumn is higher.Often there are low grade fever, weak symptom in the premorbid stage, and there are pain, burn feeling in the dermexanthesis position, and toothache can appear in trigeminal herpes zoster.According to characteristic one-sided property skin-mucosa herpes, distribute and violent pain along neural, generally be easy to diagnosis.
Still lack at present the effective medicine of generally recognized as safe for herpes zoster.
The present Research of the related medical material of Chinese medicine of the present invention is as follows:
Endoconcha Sepiae [source] is the inner shell of Sepiidae animal sepiella maindroni de Rochebrune or golden cuttlefish.[function cures mainly] salty in the mouth, puckery, slightly warm in nature.Return liver, kidney channel.Effect astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, antacid sore, removing dampness sore.
The dry rhizome of Rhizoma Cyperi [source] sedge dried tuber Cyperus rotundus L..[function cures mainly] resolving depression of regulating the flow of vital energy; Menstruction regulating and pain relieving; Antiabortive.Main distending pain over the hypochondrium; Mammary swelling is educated; Hernia pain; Menoxenia; Gastral cavity abdomen feeling of fullness pain; The belch acid regurgitation, vomiting and nausea; Abdominal pain during menstruation; Bleeding not during menses; Frequent fetal movement.
Fructus Amomi [source] be the Perenniporia martius zingiberaceous plant fruits and seeds, be the traditional Chinese medical science simply armaticity medical material commonly used.[function cures mainly] circulation of qi promoting seasoning, stomach function regulating is amusing.Fructus Amomi often cooperates with Cortex Magnoliae Officinalis, Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae etc., the diseases such as treatment fullness in the epigastrium and chest, abdominal distention and little diet.
Cortex Lycii [source] is the root bark of Solanaceae Lycium plant Fructus Lycii, includes cinnamic acid, multiple aldehydes matter, betanin and linoleic acid etc.; Cortex Lycii has significant refrigeration function, and its decoct can make blood glucose reduce, and the serum cholesterol of reduction and lipotropic effect are arranged, and the preserved material of Cortex Lycii has the effect that reduces blood pressure significantly to animal.It is cold in nature, sweet in the mouth, light.[function cures mainly] removing heat from blood moves back steaming, and clear eliminating the pathogens from the lung heat is applicable to asthenia hectic fever night sweat, lung-heat cough with asthma, the haematemesis of bleeding due to blood-heat, epistaxis, carbuncle malignant boil and pulmonary tuberculosis and vascular hypertension etc.
Radix Rubi Parvifolii [source] is in feverfew Japan Herba Gnaphalii Affinis herb.Sweet, cold.[function cures mainly] induces sweat, and heat clearing away makes eye bright, the effect of diuresis.The treatment flu, cough, headache, laryngalgia, conjunctival congestion nebula Zhang, a state in the Zhou Dywnasty, urine heat-blockage, stranguria with turbid discharge, leucorrhea, carbuncle, furuncle.
Fructus Forsythiae [source] Fructus Forsythiae is the fruit of Oleaceae plants Fructus Forsythiae, includes volatile oil, forsythol, flavonoid glycoside, alkaloid etc.; [function cures mainly] Fructus Forsythiae has broad-spectrum antibacterial action, and tell in antiinflammatory, town, diuresis and heart tonifying; Contained flavonoid glycoside can strengthen the density of blood capillary, its cold nature, bitter in the mouth, heat-clearing and toxic substances removing, mass dissipating and swelling eliminating, be applicable to warm, erysipelas, macule, carbuncle and ulcer toxic swelling and anaphylactoid purpura etc.
Radix Isatidis [source] Radix Isatidis is the root of Cruciferae Folium Isatidis platymiscium ancient name for Chinese cabbage orchid and careless Folium Isatidis, contains Radix Isatidis indigo glycoside, isatan B, B--sitosterol etc.; Remarkable antivirus action is arranged.Various pathogens is had inhibitory action, and it is cold in nature, bitter in the mouth.[function cures mainly] heat-clearing and toxic substances removing, removing heat from blood, sore-throat relieving is applicable to influenzal encephalitis, encephalitis B, pneumonia, erysipelas, pyretic toxicity and sends out speckle, acute catarrhal conjunctivitis, herpes etc.
Sanguis Draxonis [source] another name: black horse Lin exhausts, sea wax, dragon's blood, wooden Sanguis Draxonis.Resin in babassu Sanguis Draxonis fruit and the rattan.[function cures mainly] takes promoting blood circulation to remove blood stasis, analgesic therapy, external hemostasia and promoting granulation, sore orally.Cure mainly: 1. congestion amenorrhea, dysmenorrhea, postpartum stagnation.2. lump in the abdomen mass in the abdomen, breast ventral spine pain.3. traumatic injury, congestion swells and ache.4. traumatic hemorrhage, ulcer being unable to heal.
Spica Prunellae [source] Spica Prunellae is flowers or the herb of labiate Spica Prunellae, includes triterpenoid saponin and glycoside thereof unit oleanolic acid, volatile oil and vitamin, potassium chloride etc.[function cures mainly] it is cold in nature, bitter in the mouth, suffering, and the function clearing away liver-fire, Disperse hepatic depression, blood pressure lowering is applicable to the conjunctival congestion and swelling pain due to the flaming up of liver-fire, ophthalmalgia, photophobia is shed tears, headache, dizzy etc.; Be used for the scrofula due to the phlegm-fire pent-up, goiter etc.
Gold waist [source] Saxifragaceae gold waist Chrysosplenium grayanum Maxim. is with all herbal medicine.[function cures mainly] promoting pus discharge and removing toxic substances.The blackhead furuncle is controlled in external.
The Rhizoma Anemarrhenae [source] is the rhizome of the liliaceous plant Rhizoma Anemarrhenae, contain multiple Saponin and Saponin it, contain in addition two kinds of flavonoids and become Mengiferin etc.[function cures mainly] Rhizoma Anemarrhenae has obvious refrigeration function, and Epidemic Hemorrhagic Fever, epidemic encephalitis type B, pulmonary tuberculosis hectic fever all have obvious curative effects.It is cold in nature, sweet in the mouth, hardship, and function clearing away heat-fire, nourshing Yin and drynsessmoistening prescription is applicable to lung-heat cough with asthma or cough due to yin deficiency, and dysphoria with smothery sensation is quenched one's thirst, hectic fever due to YIN-deficiency consumptive fever, dysuria, the diseases such as constipation due to dry stool.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine for the treatment of herpes zoster, by selecting suitable medical material and proportioning thereof, reaches the purpose of safe and effective healing herpes zoster.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of Chinese medicine for the treatment of herpes zoster, it is characterized in that, be prepared from by the medical material of following weight proportion: 8 parts of Endoconcha Sepiaes, 12 parts of Rhizoma Cyperis, 14 parts of Fructus Amomis, 8 parts of Cortex Lycii, 12 parts of Radix Rubi Parvifoliis, 14 parts of Fructus Forsythiaes, 12 parts of Radix Isatidis, 4 parts of Sanguis Draxonis, 13 parts of Spica Prunellaes, 8 parts in golden waist, 12 parts of the Rhizoma Anemarrhenaes.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The out-patient that the inventor collects 90 routine herpes zoster between year December in October, 2009-2011 altogether, age 12-52 year, course of disease 0.5-7.Be divided at random: treatment group 60 examples, blank group 30 examples.The data there was no significant differences such as two groups of ages, the state of an illness have comparability.
2, test method
2.1 the capsule that the oral the present invention for the treatment of group makes according to specific embodiment 1, sooner or later respectively once.30 days courses for the treatment of.
2.2 blank group oral placebo capsule, sooner or later respectively once.30 days courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and the test chamber inspection is normal.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, and lab testing improves or is normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 treatment statistical result sees Table 1.
Table 1 liang group curative effect relatively
As seen, the medicine that makes of the present invention can safe and effectively be controlled herpes zoster.
The specific embodiment
In order to understand better and to implement the present invention, further specify the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take by weighing: Endoconcha Sepiae 8 grams, Rhizoma Cyperi 12 grams, Fructus Amomi 14 grams, Cortex Lycii 8 grams, Radix Rubi Parvifolii 12 grams, Fructus Forsythiae 14 grams, Radix Isatidis 12 grams, Sanguis Draxonis 4 grams, Spica Prunellae 13 grams, golden waist 8 grams, the Rhizoma Anemarrhenae 12 grams, add 8 times of water gagings, decocted 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying incapsulates shell, namely gets the capsule that meets 1 day consumption of normal adult.
Be used for the treatment of herpes zoster.Oral, every bu is taken for twice sooner or later.
Specific embodiment 2
Take by weighing: Endoconcha Sepiae 8 grams, Rhizoma Cyperi 12 grams, Fructus Amomi 14 grams, Cortex Lycii 8 grams, Radix Rubi Parvifolii 12 grams, Fructus Forsythiae 14 grams, Radix Isatidis 12 grams, Sanguis Draxonis 4 grams, Spica Prunellae 13 grams, golden waist 8 grams, the Rhizoma Anemarrhenae 12 grams, add 8 times of water gagings, decocted 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying is pulverized, and namely gets the powder that meets 1 day consumption of normal adult.
Be used for the treatment of herpes zoster.Oral, every bu is taken for twice sooner or later.
Specific embodiment 3
Take by weighing: Endoconcha Sepiae 8 grams, Rhizoma Cyperi 12 grams, Fructus Amomi 14 grams, Cortex Lycii 8 grams, Radix Rubi Parvifolii 12 grams, Fructus Forsythiae 14 grams, Radix Isatidis 12 grams, Sanguis Draxonis 4 grams, Spica Prunellae 13 grams, golden waist 8 grams, the Rhizoma Anemarrhenae 12 grams, add 8 times of water gagings, decocted 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying adds an amount of dextrin and correctives again, granulates according to this area common process, and packing can make the granule that meets 1 day consumption of normal adult.
Be used for the treatment of herpes zoster.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. Chinese medicine for the treatment of herpes zoster, it is characterized in that, be prepared from by the medical material of following weight proportion: 8 parts of Endoconcha Sepiaes, 12 parts of Rhizoma Cyperis, 14 parts of Fructus Amomis, 8 parts of Cortex Lycii, 12 parts of Radix Rubi Parvifoliis, 14 parts of Fructus Forsythiaes, 12 parts of Radix Isatidis, 4 parts of Sanguis Draxonis, 13 parts of Spica Prunellaes, 8 parts in golden waist, 12 parts of the Rhizoma Anemarrhenaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310253049.3A CN103316278B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine for treating herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310253049.3A CN103316278B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine for treating herpes zoster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103316278A true CN103316278A (en) | 2013-09-25 |
| CN103316278B CN103316278B (en) | 2014-11-05 |
Family
ID=49185511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310253049.3A Expired - Fee Related CN103316278B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine for treating herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103316278B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908556A (en) * | 2014-03-31 | 2014-07-09 | 李燕 | Traditional Chinese medicine for treating varicella |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856447A (en) * | 2010-06-12 | 2010-10-13 | 长春市南关区中医院 | Capsule capable of clearing heat and purging fire |
| CN101985030A (en) * | 2010-10-26 | 2011-03-16 | 崔宝娟 | Traditional Chinese medicine for treating herpes zoster |
| CN102423464A (en) * | 2011-12-07 | 2012-04-25 | 卢军亚 | Medicine for treating herpes zoster |
-
2013
- 2013-06-24 CN CN201310253049.3A patent/CN103316278B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101856447A (en) * | 2010-06-12 | 2010-10-13 | 长春市南关区中医院 | Capsule capable of clearing heat and purging fire |
| CN101985030A (en) * | 2010-10-26 | 2011-03-16 | 崔宝娟 | Traditional Chinese medicine for treating herpes zoster |
| CN102423464A (en) * | 2011-12-07 | 2012-04-25 | 卢军亚 | Medicine for treating herpes zoster |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908556A (en) * | 2014-03-31 | 2014-07-09 | 李燕 | Traditional Chinese medicine for treating varicella |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103316278B (en) | 2014-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101422579B (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
| CN102363039B (en) | Chinese medicine for treating rhinitis | |
| CN102895592B (en) | Chinese herbal medicine for treating reflux esophagitis | |
| CN101085314A (en) | Chinese patent medicine for treating delayed menstruation | |
| CN103316278B (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN102657725B (en) | Traditional Chinese medicine for treating constipation | |
| CN103893521A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN103055181B (en) | Traditional Chinese medicine for treating chronic erosive gastritis | |
| CN102988806B (en) | Traditional Chinese medicine for treating recurrent ulcer | |
| CN101085313A (en) | Traditional Chinese medicine preparation for treating vicarious menstruation | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
| CN104666806A (en) | Traditional Chinese medicine for treating epidemic meningitis | |
| CN103520672B (en) | The Chinese medicine for the treatment of dampness-heat of the liver pattern of syndrome menopathy | |
| CN103520631B (en) | Traditional Chinese medicine used for treating irregular menstruation | |
| CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
| CN101085316A (en) | Traditional Chinese medicine preparation for treating menstrual vertigo | |
| CN104208218B (en) | A kind of Chinese medicine for the treatment of stagnant heat type amenorrhea | |
| CN102988753B (en) | Traditional Chinese medicine for treating chronic erosive gastritis | |
| CN103536734B (en) | A kind of Chinese medicine for the treatment of the forgetful disease of deficiency of both the heart and spleen pattern of syndrome | |
| CN103656220A (en) | Traditional Chinese medicine for treating spleen-kidney-yang-deficiency type chronic enteritis | |
| CN102895607A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN102895549B (en) | Traditional Chinese medicine for treating chronic atrophic gastritis | |
| CN104288365A (en) | Traditional Chinese medicine for treating amenorrhea due to qi stagnation and blood stasis | |
| CN101279025A (en) | Chinese medicine preparation for curing melancholia | |
| CN103816442B (en) | A kind of Chinese medicine for the treatment of the urinary tract infection caused by diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: MAO JIE Free format text: FORMER OWNER: GU YANJUN Effective date: 20140922 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Mao Jie Inventor before: Gu Yanjun |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GU YANJUN TO: MAO JIE Free format text: CORRECT: ADDRESS; FROM: 315175 NINGBO, ZHEJIANG PROVINCE TO: 315041 NINGBO, ZHEJIANG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140922 Address after: 315041 No. 456, Xingning Road, Jiangdong District, Zhejiang, Ningbo Applicant after: Mao Jie Address before: Yinzhou District Lianfeng road 315175 Zhejiang city of Ningbo Province, No. 889 Applicant before: Gu Yanjun |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151210 Address after: 225200, No. 1, Sanjiang Avenue, Yanjiang Development Zone, Jiangdu District, Jiangsu, Yangzhou Patentee after: Sky, Jiangsu and pharmaceutical Co. Ltd Address before: 315041 No. 456, Xingning Road, Jiangdong District, Zhejiang, Ningbo Patentee before: Mao Jie |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141105 Termination date: 20160624 |